Perspective
Published on 27 Feb 2023
Transparency – a patient-centric view on radiopharmaceutical extravasations
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1127692
- 2,417 views
Type at least 3 characters
30 articles
Original Research
Published on 23 Nov 2022
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.1033697
- 2,496 views
- 1 citation
Original Research
Published on 23 Sep 2022
The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrier
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.1001722
- 3,767 views
- 2 citations
Policy Brief
Published on 07 Sep 2022
Radiopharmaceutical good practices: Regulation between hospital and industry
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.990330
- 8,376 views
- 4 citations
Review
Published on 16 Aug 2022
Historical efforts to develop 99mTc-based amyloid plaque targeting radiotracers
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.963698
- 2,506 views
- 2 citations
Mini Review
Published on 13 Jul 2022
Clinical Relevance of Nuclear Magnetic Resonance LipoProfile
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.960522
- 35,616 views
- 8 citations
Original Research
Published on 29 Jun 2022
DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.892147
- 3,383 views
- 6 citations
Original Research
Published on 10 May 2022
Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis – the Easy DOTA-Zoledronate
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.870910
- 1,716 views
- 1 citation
Original Research
Published on 14 Apr 2022
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.850414
- 13,873 views
- 5 citations
Review
Published on 25 Mar 2022
The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.853475
- 6,755 views
- 27 citations
Original Research
Published on 20 Jan 2022
Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.820235
- 5,129 views
- 10 citations
Original Research
Published on 13 Dec 2021
Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.799533
- 2,952 views
- 4 citations
Original Research
Published on 18 Nov 2021
Fully Automated 68Ga-Labeling and Purification of Macroaggregated Albumin Particles for Lung Perfusion PET Imaging
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.778191
- 3,445 views
- 6 citations
![Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Carbonylation: Preliminary PET Imaging in Experimental Autoimmune Encephalomyelitis Mice](https://www.frontiersin.org/files/myhome article library/772289/772289_Thumb_400.jpg)
Original Research
Published on 12 Nov 2021
Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Carbonylation: Preliminary PET Imaging in Experimental Autoimmune Encephalomyelitis Mice
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.772289
- 2,274 views
- 10 citations